Quoin pharmaceuticals to announce third quarter 2024 financial results on thursday, november 7, 2024

Ashburn, va., oct. 31, 2024 (globe newswire) -- quoin pharmaceuticals ltd. (nasdaq: qnrx) (the “company” or “quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the company plans to release its third quarter 2024 financial results before the market opens on thursday, november 7, 2024.

QNRX Ratings Summary

QNRX Quant Ranking